Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Regulatory News (ABDN)

Share Price Information for Abrdn (ABDN)

Share Price is delayed by 15 minutes
Get Live Data
238.60    -2.40 (-1.00%)
Bid:
237.20
Ask:
237.60
Spread: 0.40 (0.169%)
Market Cap: £4.27b
ABDN Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Share Chart

Governance Changes

26 Mar 2026 08:00

RNS Number : 1614Y
Aberdeen Group PLC
26 March 2026
 

Aberdeen Group plc

 

Governance Changes

 

Aberdeen Group plc ("Aberdeen" or the "Company") today provides an update on its Chair succession process and consequential interim governance changes.

 

At the Company's 2025 AGM, Sir Douglas Flint announced that he would not stand for re-election at the following year's AGM. In January 2026, the Company confirmed that Sir Douglas would step down as Chair and as a Director of the Company with effect from the conclusion of the Company's Board meeting on 28 April 2026. 

 

The process to select a permanent successor to Sir Douglas as Chair of the Company remains ongoing and the Company will provide further updates on this in due course.

 

In the interim, and until a permanent Chair is appointed, the Company confirms that Jonathan Asquith, Senior Independent Director, will assume the role of Chair of the Company, subject to regulatory approval, and Chair of the Nomination and Governance Committee with effect from the conclusion of the Company's Board meeting on 28 April 2026.

 

During the interim period, Hannah Grove, Non-Executive Director, will assume the role of Chair of the Remuneration Committee. John Devine, Non-Executive Director, will assume the role of Senior Independent Director and rejoin the Nomination and Governance Committee. Jonathan will step down as a member of the Audit and Risk Committee.

 

While performing the role of Chair, Jonathan will receive a fee of £475,000 per annum on a prorated basis in line with the Directors' Remuneration Policy approved by shareholders at the 2023 AGM. Jonathan will receive no additional director fees in relation to his other roles in the Company during the period of his interim appointment.

 

Jonathan Asquith said: "On behalf of the Board, I would like to thank Sir Douglas for his exceptional contribution to the Company since joining the Board in 2018. His chairmanship has played a pivotal role in repositioning Aberdeen for success as a leading UK wealth and investments group. On behalf of my colleagues on the Board, I wish him all the very best for the future.

 

I look forward to continuing to work with Jason and his team to ensure the Company doesn't miss a beat in the execution of its growth strategy."

 

Sir Douglas Flint said: "It has been a huge privilege to serve as Chair of Aberdeen. In what has been quite a journey, I am really proud of what the Board and the executive team with the support of our colleagues have achieved together, including simplifying the Group and sharpening our strategic priorities. Jason is leading a first-rate executive team, with a clear strategy aimed at building the UK's leading wealth and investments group. I would like to thank my Aberdeen colleagues for their commitment and support, and I wish Jonathan, Jason and everyone at Aberdeen continued success."

 

The Financial Conduct Authority has been notified of the appointment of Jonathan Asquith as Chair of the Company and the appointment of Hannah Grove as Chair of the Remuneration Committee. Their respective appointments are subject to receipt of relevant regulatory approvals.

 

This announcement is made pursuant to UKLR 6.4.6R.

 

26 March 2026

 

Enquiries:

 

Media

Duncan Young

 

 

+44 (0) 7920 868 865

 

Group Secretariat

Iain Jones

 

 

+44 (0) 7464 917 797

 

* Calls may be monitored and/or recorded to protect both you and us and help with our training. Call charges will vary.

 

 

END

 

LEI number of Aberdeen Group plc: 0TMBS544NMO7GLCE7H90

 

Notes to Editors

 

For the purposes of section 430(2B) of the Companies Act 2006, Sir Douglas Flint will receive his Chair fee (£475,000 per annum) on a prorated basis until 28 April 2026. He is not entitled to any payments for loss of office.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDXSUDDGLU
Date   Source Headline
7th Feb 20252:37 pmRNSHolding(s) in Company
6th Feb 20254:19 pmRNSHolding(s) in Company
3rd Feb 20254:46 pmRNSHolding(s) in Company
3rd Feb 202512:22 pmRNSTotal Voting Rights
23rd Jan 20254:52 pmRNSHolding(s) in Company
21st Jan 20253:22 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ4 2024 AUMA & Flows Trading Update
20th Jan 20257:00 amRNSHolding(s) in Company
2nd Jan 20253:33 pmRNSHolding(s) in Company
2nd Jan 202511:23 amRNSTotal Voting Rights
23rd Dec 20242:40 pmRNSHolding(s) in Company
19th Dec 202410:10 amRNSDirector/PDMR Shareholding
16th Dec 20245:05 pmRNSHolding(s) in Company
16th Dec 20244:30 pmRNSDirectorate Change
10th Dec 202410:19 amRNSHolding(s) in Company
9th Dec 20247:00 amRNSHolding(s) in Company
6th Dec 202411:35 amRNSForm 8.3 - Tritax Eurobox plc
3rd Dec 20249:40 amRNSTR-1:Notification of major holdings
2nd Dec 20249:11 amRNSTotal Voting Rights
28th Nov 202412:44 pmRNSForm 8.3 - Direct Line Insurance Group plc
28th Nov 202412:40 pmRNSForm 8.3 - Aviva plc
27th Nov 202411:00 amRNSHolding(s) in Company
26th Nov 20244:56 pmRNSHolding(s) in Company
26th Nov 202412:40 pmRNSForm 8.3 - Volex plc
18th Nov 202412:50 pmRNSForm 8.3 - Volex plc
18th Nov 202412:48 pmRNSForm 8.3 - TT Electronics plc
18th Nov 202411:06 amRNSForm 8 (DD) - SEGRO plc
15th Nov 202410:47 amRNSForm 8 (DD) - SEGRO plc
13th Nov 20242:38 pmRNSHolding(s) in Company
12th Nov 202410:26 amRNSForm 8 (DD) - SEGRO plc
12th Nov 20247:00 amRNSHolding(s) in Company
8th Nov 202410:15 amRNSForm 8 (DD) - SEGRO plc
5th Nov 202411:13 amRNSForm 8 (DD) - SEGRO plc
4th Nov 20249:47 amRNSForm 8 (DD) - SEGRO plc
1st Nov 202410:20 amRNSTotal Voting Rights
1st Nov 20249:44 amRNSForm 8 (DD) - SEGRO plc
28th Oct 202410:53 amRNSForm 8 (DD) - SEGRO plc
24th Oct 20247:00 amRNSQ3 2024 AUMA & Flows Trading Update
23rd Oct 202411:07 amRNSForm 8 (DD) - SEGRO plc
22nd Oct 20245:04 pmRNSDirector Declaration
21st Oct 202411:02 amRNSForm 8 (DD) - SEGRO plc
18th Oct 20242:09 pmRNSBlock listing Interim Review
16th Oct 202411:02 amRNSForm 8 (DD) - SEGRO plc
15th Oct 20248:38 amRNSHolding(s) in Company
9th Oct 20243:30 pmRNSHolding(s) in Company
9th Oct 20241:41 pmRNSHolding(s) in Company
9th Oct 202410:12 amRNSForm 8 (DD) - SEGRO plc
1st Oct 202410:20 amRNSHolding(s) in Company
1st Oct 20249:45 amRNSTotal Voting Rights
30th Sep 20245:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.